What is MapLight Therapeutics, Inc. 's D&A?

MapLight Therapeutics, Inc. (MPLT) reported D&A of $162K in Q1 2026.

How has MapLight Therapeutics, Inc. 's D&A changed year-over-year?

MapLight Therapeutics, Inc. 's D&A decreased by 2.4% year-over-year, from $166K to $162K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

MapLight Therapeutics, Inc. MPLT D&A

D&A at other companies

Bristol-Myers SquibbBMY

$594M-41.3%

Johnson & JohnsonJNJ

$2B+13.1%

Neurocrine BiosciencesNBIX

$7.2M+9.1%

Acadia PharmaceuticalsACAD

$271K+18.3%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$82K+3.8%

MeiraGTx Holdings plcMGTX

$3.01M-2.4%

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B+100%

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's D&A?: MapLight Therapeutics, Inc. (MPLT) reported D&A of $162K in Q1 2026.
How has MapLight Therapeutics, Inc. 's D&A changed year-over-year?: MapLight Therapeutics, Inc. 's D&A decreased by 2.4% year-over-year, from $166K to $162K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.